Dx Deals: Abbott Closes Exact Sciences Acquisition, Takes Control of Cologuard Franchise
Biotech giant purchased the company for $21 billion, one of the largest deals in clinical lab history
Biotech giant purchased the company for $21 billion, one of the largest deals in clinical lab history
Becton Dickinson divisions responsible for $3.4 billion in annual revenue are on the block
Quest Diagnostics will find out as it launches a new health coaching business that relies on lab testing, via its Pack Health subsidiary
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation
$152.1 million SYNLAB deal is expected to create a new channel for Labcorp to market its sophisticated specialty assays
The rounds of funding to Clarapath, PreciseDx, and Precision Epigenomics come at a time when other M&A activity is seasonally slow
The roughly $1 billion deal will boost the company’s annual revenue by about 7 percent, and will give Quest a stronger presence in Canada
Though the two national players have closed dozens of such deals over the past decade, much runway for new transactions apparently remains
Deal is expected to give the lab giant a big boost in deploying artificial intelligence in the pathology space.
Most of Invitae's employees will be hired by Labcorp, which expects the deal to add about $275 million in annual revenue